Tau protein abnormalities associated with the progression of alzheimer disease type dementia

被引:60
|
作者
Haroutunian, V.
Davies, P.
Vianna, C.
Buxbaum, J. D.
Purohit, D. P.
机构
[1] Vet Adm Med Ctr, Dept Psychiat, Bronx, NY 10468 USA
[2] Mt Sinai Sch Med, Dept Psychiat, New York, NY 10029 USA
[3] Albert Einstein Coll Med, Dept Pathol & Neurosci, Bronx, NY 10461 USA
[4] Mt Sinai Sch Med, Dept Pathol, New York, NY 10029 USA
关键词
Alzheimer disease; neurofibrillary tangles; tau; dementia; PAIRED HELICAL FILAMENTS; MILD COGNITIVE IMPAIRMENT; PREFRONTAL CORTEX AREA-9; NEUROFIBRILLARY TANGLES; REGIONAL-DISTRIBUTION; STEREOLOGIC ANALYSIS; BILATERAL SYMMETRY; NEURITIC PLAQUES; OLD PEOPLE; PATHOLOGY;
D O I
10.1016/j.neurobiolaging.2005.11.001
中图分类号
R592 [老年病学]; C [社会科学总论];
学科分类号
03 ; 0303 ; 100203 ;
摘要
The degree to which neurofibrillary tangles (NIFT), the hallmark lesions of Alzheimer disease (AD), contribute to the development of the cognitive symptoms of AD has been debated. NFTs are comprised of abnormally phosphorylated and conformationally altered tau proteins. Conformational changes in tau have been proposed to be among the earliest neurobiological changes in AD. This study examined whether conformational changes detected by antibodies MCl and TG3 represent early abnormalities in the disease process by assessing their presence at different stages of dementia in multiple brain regions. Postmortem specimens from several neocortical regions were examined for conformational changes in tau by ELISA in subjects [n = 81] who died at different stages of cognitive impairment. Concentrations of conformationally altered tau increased with increasing dementia severity and the levels of MCl immunoreactivity increased in the frontal cortex of mildly demented subjects before the appearance of NFT bearing neurons, suggesting that conformational alterations in tau occur early in the course of AD and its cognitive symptoms and may precede histologically identified NFTs. (c) 2005 Elsevier Inc. All rights reserved.
引用
收藏
页码:1 / 7
页数:7
相关论文
共 50 条
  • [31] Tau PET Imaging in Alzheimer’s Disease
    Nobuyuki Okamura
    Ryuichi Harada
    Shozo Furumoto
    Hiroyuki Arai
    Kazuhiko Yanai
    Yukitsuka Kudo
    Current Neurology and Neuroscience Reports, 2014, 14
  • [32] Neuropathologic criteria for diagnosing Alzheimer disease in persons with pure dementia of Alzheimer type
    McKeel, DW
    Price, JL
    Miller, JP
    Grant, EA
    Xiong, CJ
    Berg, L
    Morris, JC
    JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 2004, 63 (10) : 1028 - 1037
  • [33] Dementia Mimicking Alzheimer's Disease Owing to a Tau Mutation: CSF and PET Findings
    Tolboom, Nelleke
    Koedam, Esther L. G. E.
    Schott, Jonathan M.
    Yaqub, Maqsood
    Blankenstein, Marinus A.
    Barkhof, Frederik
    Pijnenburg, Yolande A. L.
    Lammertsma, Adriaan A.
    Scheltens, Philip
    van Berckel, Bart N. M.
    ALZHEIMER DISEASE & ASSOCIATED DISORDERS, 2010, 24 (03) : 303 - 307
  • [34] The sterol regulatory element-binding protein 2 is dysregulated by tau alterations in Alzheimer disease
    Wang, Chunyu
    Zhao, Fanpeng
    Shen, Katie
    Wang, Wenzhang
    Siedlak, Sandra L.
    Lee, Hyoung-gon
    Phelix, Clyde F.
    Perry, George
    Shen, Lu
    Tang, Beisha
    Yan, Riqiang
    Zhu, Xiongwei
    BRAIN PATHOLOGY, 2019, 29 (04) : 530 - 543
  • [35] Total and phosphorylated tau protein as biological markers of Alzheimer's disease
    Hampel, Harald
    Blennow, Kaj
    Shaw, Leslie M.
    Hoessler, Yvonne C.
    Zetterberg, Henrik
    Trojanowski, John Q.
    EXPERIMENTAL GERONTOLOGY, 2010, 45 (01) : 30 - 40
  • [36] Immunomodulation of Memory-Impairing Protein Tau in Alzheimer's Disease
    Zilka, Norbert
    Stozicka, Zuzana
    Cente, Martin
    Kazmerova, Zuzana
    Kovacech, Branislav
    Novak, Michal
    NEURODEGENERATIVE DISEASES, 2012, 10 (1-4) : 242 - 245
  • [37] Hyperphosphorylation of Microtubule-Associated Protein Tau: A Promising Therapeutic Target for Alzheimer Disease
    Gong, C. -X.
    Iqbal, K.
    CURRENT MEDICINAL CHEMISTRY, 2008, 15 (23) : 2321 - 2328
  • [38] Phosphorylation of tau protein at sites Ser396-404 is one of the earliest events in Alzheimer's disease and Down syndrome
    Mondragon-Rodriguez, S.
    Perry, G.
    Luna-Munoz, J.
    Acevedo-Aquino, M. C.
    Williams, S.
    NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY, 2014, 40 (02) : 121 - 135
  • [39] Relationship between Serum Levels of Tau Fragments and Clinical Progression of Alzheimer's Disease
    Henriksen, Kim
    Byrjalsen, Inger
    Christiansen, Claus
    Karsdal, Morten Asser
    JOURNAL OF ALZHEIMERS DISEASE, 2015, 43 (04) : 1331 - 1341
  • [40] Role of tau protein in Alzheimer's disease: The prime pathological player
    Muralidar, Shibi
    Ambi, Senthil Visaga
    Sekaran, Saravanan
    Thirumalai, Diraviyam
    Palaniappan, Balamurugan
    INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES, 2020, 163 : 1599 - 1617